These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Progesterone and the risk of arterial and venous thrombosis]. Perry C; Berliner S Harefuah; 1998 Apr; 134(8):633-7. PubMed ID: 10911430 [No Abstract] [Full Text] [Related]
10. Pitfalls of pharmacoepidemiology. Skegg DC BMJ; 2000 Nov; 321(7270):1171-2. PubMed ID: 11073496 [No Abstract] [Full Text] [Related]
11. The third generation pill controversy ("continued"). Drife JO BMJ; 2001 Jul; 323(7305):119-20. PubMed ID: 11463662 [No Abstract] [Full Text] [Related]
12. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study. Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G BMJ; 2001 Apr; 322(7293):1024-5. PubMed ID: 11325765 [No Abstract] [Full Text] [Related]
13. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives. Vandenbrouke JP; Bloemenkamp KW; Rosendaal FR; Helmerhorst FM BMJ; 2000 Jan; 320(7226):57-8. PubMed ID: 10671043 [No Abstract] [Full Text] [Related]
14. [Oral contraceptives and the risk of venous thromboembolism]. Uchikova E; Malinova M; Milchev N Akush Ginekol (Sofiia); 2002; 41(2):46-8. PubMed ID: 12066553 [No Abstract] [Full Text] [Related]
15. Risk of venous thromboembolism and oral contraceptives. Gompel A; Carpentier S; Francès C; Piette JC Lancet; 2002 Apr; 359(9314):1348-9. PubMed ID: 11965310 [No Abstract] [Full Text] [Related]
16. Diagnostic suspicion and referral bias in studies of venous thromboembolism and oral contraceptive use. Vandenbroucke JP; Bloemenkamp KW; Helmerhorst FM; Büller HR; Rosendaal FR Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):56-7. PubMed ID: 11334478 [No Abstract] [Full Text] [Related]
17. [Oral contraceptives increase deep venous thrombosis in smoking women]. Tsankova V; Petrov V; Astrug A Akush Ginekol (Sofiia); 2010; 49(5):8-13. PubMed ID: 21268396 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease. Mammen EF Hematol Oncol Clin North Am; 2000 Oct; 14(5):1045-59, vii-viii. PubMed ID: 11005033 [TBL] [Abstract][Full Text] [Related]
19. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]
20. Claim launched against makers of third generation pill. Dyer C BMJ; 2002 Mar; 324(7337):561. PubMed ID: 11884306 [No Abstract] [Full Text] [Related] [Next] [New Search]